Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac assist devices: bridging and beyond

C H Van Meter1, F W Smart, P M McFadden

  • 1Thoracic Cardiovascular Surgery Dept, Ochsner Medical Institutions, New Orleans, LA 70121.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The organ allocation controversy: how did we arrive here?

Ochsner journal·2011
Same author

Advances in lung transplantation.

Ochsner journal·2011
Same author

Issue editor.

Ochsner journal·2011
Same author

Minimally invasive surgical procedures.

Ochsner journal·2011
Same author

Minimally invasive thoracic surgery.

Ochsner journal·2011
Same author

Minimally invasive coronary artery bypass surgery.

Ochsner journal·2011

Left ventricular assist devices (LVADs) help patients awaiting heart transplants by preventing end-stage heart failure complications. These safe devices may eventually serve as an alternative to donor organs.

Area of Science:

  • Cardiology
  • Medical Devices
  • Transplantation Medicine

Background:

  • High mortality rates persist for patients awaiting cardiac transplantation.
  • End-stage heart failure presents significant physiological challenges.
  • Left ventricular assist devices (LVADs) are increasingly utilized in major transplant centers.

Purpose of the Study:

  • To evaluate the role of LVADs in managing patients awaiting heart transplantation.
  • To assess the safety and efficacy of LVADs in preserving physiological state.
  • To explore the potential of LVADs as a solution for donor organ shortages.

Main Methods:

  • Review of current practices in major transplant centers.
  • Analysis of patient outcomes utilizing LVADs.

Related Experiment Videos

  • Assessment of device safety and physiological impact.

    • Main Results:

    • LVADs are widely adopted to mitigate complications of end-stage heart failure.
    • Patients supported by LVADs maintain a good physiological state for transplantation.
    • The devices demonstrate a favorable safety profile.

    Conclusions:

    • LVADs are a crucial intervention for patients awaiting heart transplantation.
    • These devices effectively manage end-stage heart failure complications.
    • LVADs show promise as a future substitute for limited donor organs.